Pharmprom has Refocused on the Production of Expensive Medicinal Products

The volume of medicinal products production in Russia at the end of Q1-Q3 2021 reached 432.7 billion rubles, which is 20% more than last year's figures. According to RNC Pharma data, the high dynamics has been maintained for the third year in a row. As for the natural indicators, shipments in packages over the past year decreased by 16%, a total of 2.98 billion packages were produced.

The results of September showed an increase in rubles at the level of 0.3%, which is the second result since the end of the year in terms of the month. In total, this month domestic manufacturers released medicinal products worth 48 billion rubles. But analysts explain the modest results by the effect of a high base last year, when September saw the peak of production associated with the rise in the incidence of coronavirus infection. Moreover, over the year the range of products has changed significantly, in particular, this year the pharmaceutical industry has refocused on the production of more expensive medicinal products.

The unevenness of production dynamics with regard to prescription and over-the-counter medicinal products at the end of Q1-Q3 2021 is still observed; when calculating in packages, the growth in the group of over-the-counter medicinal products was fixed at -21.4%, the result for the category of prescription medicinal products is about two times better (-9.4%).

Source: Remedium